171 related articles for article (PubMed ID: 14503915)
1. Protein kinase C: a target for anticancer drugs?
Mackay HJ; Twelves CJ
Endocr Relat Cancer; 2003 Sep; 10(3):389-96. PubMed ID: 14503915
[TBL] [Abstract][Full Text] [Related]
2. Protein kinase C: a worthwhile target for anticancer drugs?
Caponigro F; French RC; Kaye SB
Anticancer Drugs; 1997 Jan; 8(1):26-33. PubMed ID: 9147607
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase C as a drug target: implications for drug or diet prevention and treatment of cancer.
Carter CA
Curr Drug Targets; 2000 Sep; 1(2):163-83. PubMed ID: 11465069
[TBL] [Abstract][Full Text] [Related]
4. Protein kinase C: a target for anticancer drugs?
Maioli E; Fortino V
Endocr Relat Cancer; 2004 Jun; 11(2):161-2. PubMed ID: 15163295
[No Abstract] [Full Text] [Related]
5. Protein kinase C targeting in antineoplastic treatment strategies.
Jarvis WD; Grant S
Invest New Drugs; 1999; 17(3):227-40. PubMed ID: 10665476
[TBL] [Abstract][Full Text] [Related]
6. New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.
Faivre S; Djelloul S; Raymond E
Semin Oncol; 2006 Aug; 33(4):407-20. PubMed ID: 16890796
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-beta as a therapeutic target in breast cancer.
Sledge GW; Gökmen-Polar Y
Semin Oncol; 2006 Jun; 33(3 Suppl 9):S15-8. PubMed ID: 16797377
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneity of proteinkinase C activity and PKC-zeta expression in clinical breast carcinomas.
Schöndorf T; Kurbacher CM; Becker M; Warm M; Kolhagen H; Göhring UJ
Clin Exp Med; 2001 Mar; 1(1):1-8. PubMed ID: 11467396
[TBL] [Abstract][Full Text] [Related]
9. Antisense inhibition of protein kinase Calpha reverses the transformed phenotype in human lung carcinoma cells.
Wang XY; Repasky E; Liu HT
Exp Cell Res; 1999 Jul; 250(1):253-63. PubMed ID: 10388539
[TBL] [Abstract][Full Text] [Related]
10. Cyclin-dependent kinase and protein kinase C inhibitors: a novel class of antineoplastic agents in clinical development.
Kaubisch A; Schwartz GK
Cancer J; 2000; 6(4):192-212. PubMed ID: 11038138
[TBL] [Abstract][Full Text] [Related]
11. Protein kinase C inhibitors as novel anticancer drugs.
Goekjian PG; Jirousek MR
Expert Opin Investig Drugs; 2001 Dec; 10(12):2117-40. PubMed ID: 11772309
[TBL] [Abstract][Full Text] [Related]
12. A high throughput system for the evaluation of protein kinase C inhibitors based on Elk1 transcriptional activation in human astrocytoma cells.
Sharif TR; Sharif M
Int J Oncol; 1999 Feb; 14(2):327-35. PubMed ID: 9917510
[TBL] [Abstract][Full Text] [Related]
13. Protein kinase C inhibitors.
Swannie HC; Kaye SB
Curr Oncol Rep; 2002 Jan; 4(1):37-46. PubMed ID: 11734112
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxicity induced by manipulation of signal transduction pathways is associated with down-regulation of Bcl-2 but not Mcl-1 in MCF-7 human breast cancer.
Hu Y; Dragowska WH; Wallis A; Duronio V; Mayer L
Breast Cancer Res Treat; 2001 Nov; 70(1):11-20. PubMed ID: 11767000
[TBL] [Abstract][Full Text] [Related]
15. Analogs of staurosporine: potential anticancer drugs?
Gescher A
Gen Pharmacol; 1998 Nov; 31(5):721-8. PubMed ID: 9809468
[TBL] [Abstract][Full Text] [Related]
16. Targeting protein kinase C (PKC) in physiology and cancer of the gastric cell system.
Fährmann M
Curr Med Chem; 2008; 15(12):1175-91. PubMed ID: 18473812
[TBL] [Abstract][Full Text] [Related]
17. Preclinical and clinical development of novel agents that target the protein kinase C family.
Serova M; Ghoul A; Benhadji KA; Cvitkovic E; Faivre S; Calvo F; Lokiec F; Raymond E
Semin Oncol; 2006 Aug; 33(4):466-78. PubMed ID: 16890801
[TBL] [Abstract][Full Text] [Related]
18. Classical PKC isoforms in cancer.
Martiny-Baron G; Fabbro D
Pharmacol Res; 2007 Jun; 55(6):477-86. PubMed ID: 17548205
[TBL] [Abstract][Full Text] [Related]
19. Preclinical studies of molecular-targeting diagnostic and therapeutic strategies against breast cancer.
Fujii T; Yokoyama G; Takahashi H; Namoto R; Nakagawa S; Toh U; Kage M; Shirouzu K; Kuwano M
Breast Cancer; 2008; 15(1):73-8. PubMed ID: 18224398
[TBL] [Abstract][Full Text] [Related]
20. Modulation of protein kinase C in antitumor treatment.
Hofmann J
Rev Physiol Biochem Pharmacol; 2001; 142():1-96. PubMed ID: 11190577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
